The development of a drug that mimics the pain-relieving activity of opioid compounds, but has fewer side effects, points to an effective strategy for the discovery of many types of drug. See Article p.185
Notes
References
Brownstein, M. J. Proc. Natl Acad. Sci. USA 90, 5391–5393 (1993).
Trang, T. et al. J. Neurosci. 35, 13879–13888 (2015).
Manglik, A. et al. Nature 537, 185–190 (2016).
Kieffer, B. L. & Gavériaux-Ruff, C. Prog. Neurobiol. 66, 285–306 (2002).
Matthes, H. W. et al. Nature 383, 819–823 (1996).
Galandrin, S., Oligny-Longpré, G. & Bouvier, M. Trends Pharmacol. Sci. 28, 423–430 (2007).
Kobilka, B. & Schertler, G. F. Trends Pharmacol. Sci. 29, 79–83 (2008).
Manglik, A. et al. Nature 485, 321–326 (2012).
Audet, M. & Bouvier, M. Cell 151, 14–23 (2012).
Raehal, K. M., Schmid, C. L., Groer, C. E. & Bohn, L. M. Pharmacol. Rev. 63, 1001–1019 (2011).
DeWire, S. M. et al. J. Pharmacol. Exp. Ther. 344, 708–717 (2013).
Shoichet, B. K. & Kobilka, B. K. Trends Pharmacol. Sci. 33, 268–272 (2012).
Author information
Authors and Affiliations
Corresponding author
Related links
Related links
Related links in Nature Research
Rights and permissions
About this article
Cite this article
Kieffer, B. Designing the ideal opioid. Nature 537, 170–171 (2016). https://doi.org/10.1038/nature19424
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature19424
- Springer Nature Limited
This article is cited by
-
Modulatory effect of opioid administration on the activity of cholinesterase enzyme: a systematic review of mice/rat models
Environmental Science and Pollution Research (2021)
-
A Large-Scale Observational Study on the Temporal Trends and Risk Factors of Opioid Overdose: Real-World Evidence for Better Opioids
Drugs - Real World Outcomes (2021)
-
Better agonist for the opioid receptors
Chemistry Central Journal (2018)
-
Opioid receptors: drivers to addiction?
Nature Reviews Neuroscience (2018)